PETMED EXPRESS Reports Staggering Losses and Missed Revenue Targets
June 23, 2023
🌧️Trending News
PETMED ($NASDAQ:PETS): According to the announcement, PetMed Express‘ GAAP earnings per share of -$0.25 was $0.39 lower than expected, while their revenue of $62.4M was $3.35M short of the forecast. PetMed Express, Inc. is an online pet pharmacy based in Florida, USA. Their mission is to provide the highest quality pet medications at the lowest prices to customers across the country. The company also offers a wide range of pet health products such as food, treats, preventative care items, and supplies.
In addition, PetMed Express has an online store that provides convenient access to pet medications and other pet health supplies.
Stock Price
The PETMED EXPRESS stock opened at $14.8 and closed at $15.2, representing a 3.1% increase from the prior closing price of 14.7. The losses and missed revenue targets were attributed to the recent economic downturn, which has caused decreased consumer spending. The company also noted that increased competition in the online pet pharmacy retail space had a negative effect on sales figures. Despite the current setbacks, PETMED EXPRESS remains confident that it will be able to bounce back and regain its position as the leader in the online pet pharmacy retail space. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Petmed Express. More…
| Total Revenues | Net Income | Net Margin |
| 256.86 | 0.23 | 0.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Petmed Express. More…
| Operations | Investing | Financing |
| 27.8 | -10.26 | -24.54 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Petmed Express. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 164.12 | 40.32 | 5.87 |
Key Ratios Snapshot
Some of the financial key ratios for Petmed Express are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -3.3% | -17.7% | -0.6% |
| FCF Margin | ROE | ROA |
| 8.8% | -0.7% | -0.5% |
Analysis
GoodWhale has conducted an analysis of PETMED EXPRESS‘s financials, and the results were impressive. The Star Chart gave PETMED EXPRESS a health score of 10/10, meaning that its cashflows and debt are strong enough to sustain future operations even in times of crisis. We also found that PETMED EXPRESS had a strong asset base, medium dividend, profitability, and weak growth. Based on these results, we classified PETMED EXPRESS as a ‘cow’ – a company with a track record of paying out consistent and sustainable dividends. This type of company may be of interest to investors who are seeking steady returns over time with minimal risk. More…
Peers
PetMed Express Inc is one of the largest online pet pharmacies in the United States. The company offers a wide range of pet medications, supplies, and products at competitive prices. PetMed Express also offers a wide variety of services, including prescription refill reminders, online pet health information, and a pet health hotline. The company’s main competitors are Oriola Corp, Trxade Health Inc, Yunnan Jianzhijia Health-Chain Co Ltd.
– Oriola Corp ($LTS:0NER)
Oriola Corporation is a Finnish company that provides branded pharmaceuticals and services to the pharmaceutical industry and retail pharmacies. The company has a market capitalization of €330.77 million and a return on equity of 7.73%. Oriola Corporation is a leading provider of branded pharmaceuticals and services to the pharmaceutical industry and retail pharmacies. The company offers a wide range of products and services, including branded pharmaceuticals, generic pharmaceuticals, over-the-counter (OTC) products, medical devices, and services.
– Trxade Health Inc ($NASDAQ:MEDS)
Trxade Health Inc is a healthcare company that focuses on providing services and products to the healthcare industry. The company has a market cap of 8.16M as of 2022 and a Return on Equity of -110.47%. Trxade Health Inc’s main products and services include healthcare software and services, medical supplies, and pharmaceuticals. The company operates in the United States and Canada.
– Yunnan Jianzhijia Health-Chain Co Ltd ($SHSE:605266)
Yunnan Jianzhijia Health-Chain Co Ltd is a Chinese company that focuses on the development and application of health-related big data technology. The company’s products and services include a health information platform, a health data application platform, and a health management platform. As of 2022, Yunnan Jianzhijia Health-Chain Co Ltd has a market cap of 5.46B and a Return on Equity of 11.7%.
Summary
Revenues totaled $62.4M, missing estimates by $3.35M. Despite the company’s struggles with earnings, the stock price moved up the same day in response to the report. As an animal-focused pharmaceuticals provider, PetMed Express’s potential lies in its ability to continue to capitalize on opportunities in the pet healthcare market. Investors should keep an eye on the company’s performance going forward and how it deals with the current challenges.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
